PFE - Pfizer Projected Sales Volume

Public company logo of Pfizer Corporation (PFE)

The sales forecast model for Pfizer Inc. (PFE) demonstrates how the decline in COVID-related revenues is being offset by new oncology drugs. The business relies on the global immunology market and the acquisition of biotech firms. Its defensive profile and the seasonality of respiratory infections guarantee a steady cash flow. Meanwhile, the 266.08 level reflects the current value of this metric, helping investors assess the revenue trajectory for portfolio construction.

Company Expected Revenue: Pfizer Corp (PFE) for 07/04/2022 - 11/13/2026

Analytical breakdowns and data insights for company Pfizer Inc (PFE)

- stock value and consensus price forecast:
Price Chart Pfizer Inc.|PFE - Broker Consensus Forecast
- market capitalization statistics:
Market Capitalization Pfizer Inc|PFE - Full Takeover Company Value
- book capitalization information:
Net Assets per Single Share Pfizer|PFE - Net Asset Value|Market Capitalization to Book Value Ratio pfizer.com|PFE - Total Asset Value of Company
- debt and liquidity data:
Total Debt to Capital Pfizer Inc.|PFE - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity Ratio Pfizer Corporation|PFE - Company Aggregate Indebtedness|Debts to Book Capitalization Pfizer Inc|PFE - Long-Term Debt|Company Short-Term Debt Pfizer|Quick Liquidity Indicator pfizer.com
- company profitability and valuation multiples indicators:
PFE - Final Profit|Projected Future Earnings Pfizer Inc.|PFE - Business Payback Period|Future Price to Earnings Pfizer|PFE - Growth-Adjusted P/E Ratio|EV/EBITDA Multiple Pfizer Inc|PFE - Operating profit before deduction of amortization|Net earnings per share for the last 12 months Pfizer|PFE - Net earnings per share for the last four quarters|Year-over-year earnings per share growth for the last twelve months pfizer.com|PFE - Earnings per share trend in current year|Earnings growth forecast for next year Pfizer Inc.
- sales and revenue indicators:
PFE - Company Annual Revenue|Projected Sales Volume Pfizer Inc.|PFE - Price to Sales|Price-to-Projected Revenue Ratio Pfizer Inc
Fundamental company valuation:Pfizer Inc.
Brand item of Pfizer Corp

Pfizer Inc. (PFE) massive R&D investments and stringent FDA oversight create high barriers to entry in the sector, making the organization's projected sales volume a key indicator of market expansion. This metric aggregates forecasted cash flows from drug sales, allowing investors to assess the business's fundamental stability and the asset's long-term capitalization potential through the lens of competitive advantages.

Competitors of Pfizer Inc. (PFE)

Company Projected Revenue Eli Lilly and Company (LLY)|abbvie.com - Company Revenue Forecast|Projected Sales Volume AZN (AstraZeneca)|Company Sales Forecast Novartis Corporation|MRK - Company Projected Revenue|Company Expected Revenue NVO|AMGN: Projected Sales Volume|Company Expected Revenue SNY (sanofi.com)|BMY (Bristol Myers Squibb) - Projected Sales Volume|GSK Corp (GSK) - Company Future Sales|Company Future Sales Volume TAK (Takeda Pharmaceutical Company Limited)|TEVA: Company Expected Revenue|Projected Sales Volume RDY (Dr. Reddy's Laboratories)|viatris.com (VTRS) - Company Expected Sales Volume|ROIV - Company Projected Revenue|Company Future Revenue ZLAB (Zai Lab Ltd)|BHC (Valeant Pharmaceuticals) - Company Future Sales Volume|Cosmos Health Inc - Company Future Revenue